These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
903 related articles for article (PubMed ID: 34755818)
21. Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants. Mertens J; Coppens J; Loens K; Le Mercier M; Xavier BB; Lammens C; Vandamme S; Jansens H; Goossens H; Matheeussen V Clin Microbiol Infect; 2022 Jan; 28(1):124-129. PubMed ID: 34537361 [TBL] [Abstract][Full Text] [Related]
22. Genomic Epidemiology of SARS-CoV-2 in Tocantins State and the Diffusion of P.1.7 and AY.99.2 Lineages in Brazil. de Souza UJB; Dos Santos RN; de Melo FL; Belmok A; Galvão JD; de Rezende TCV; Cardoso FDP; Carvalho RF; da Silva Oliveira M; Ribeiro Junior JC; Gabev EE; Sabino EC; Arns CW; Ribeiro BM; Spilki FR; Campos FS Viruses; 2022 Mar; 14(4):. PubMed ID: 35458389 [TBL] [Abstract][Full Text] [Related]
23. Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants. Lamarca AP; de Almeida LGP; Francisco RDS; Cavalcante L; Brustolini O; Gerber AL; Guimarães APC; de Oliveira TH; Dos Santos Nascimento ÉR; Policarpo C; de Souza IV; de Carvalho EM; Ribeiro MS; Carvalho S; Dias da Silva F; de Oliveira Garcia MH; de Souza LM; Da Silva CG; Ribeiro CLP; Cavalcanti AC; de Mello CMB; Tanuri A; Vasconcelos ATR Microb Genom; 2022 Sep; 8(9):. PubMed ID: 36106981 [TBL] [Abstract][Full Text] [Related]
24. First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission. Sola Campoy PJ; Buenestado-Serrano S; Pérez-Lago L; Rodriguez-Grande C; Catalán P; Andrés-Zayas C; Alcalá L; Losada C; Rico-Luna C; Muñoz P; García de Viedma D; Enferm Infecc Microbiol Clin (Engl Ed); 2022 May; 40(5):262-265. PubMed ID: 35577445 [TBL] [Abstract][Full Text] [Related]
25. Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020. Claro IM; da Silva Sales FC; Ramundo MS; Candido DS; Silva CAM; de Jesus JG; Manuli ER; de Oliveira CM; Scarpelli L; Campana G; Pybus OG; Sabino EC; Faria NR; Levi JE Emerg Infect Dis; 2021 Mar; 27(3):970-972. PubMed ID: 33496249 [TBL] [Abstract][Full Text] [Related]
26. Turnover of SARS-CoV-2 Lineages Shaped the Pandemic and Enabled the Emergence of New Variants in the State of Rio de Janeiro, Brazil. Francisco Junior RDS; Lamarca AP; de Almeida LGP; Cavalcante L; Machado DT; Martins Y; Brustolini O; Gerber AL; Guimarães APC; Gonçalves RB; Alves C; Mariani D; Cruz TF; de Souza IV; de Carvalho EM; Ribeiro MS; Carvalho S; da Silva FD; Garcia MHO; de Souza LM; da Silva CG; Ribeiro CLP; Cavalcanti AC; de Mello CMB; Struchiner CJ; Tanuri A; de Vasconcelos ATR Viruses; 2021 Oct; 13(10):. PubMed ID: 34696443 [TBL] [Abstract][Full Text] [Related]
27. Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil. Slavov SN; Giovanetti M; Dos Santos Bezerra R; Fonseca V; Santos EV; Rodrigues ES; Adelino T; Xavier J; Borges JS; Evaristo M; Lima MT; de Carvalho Pereira G; Yamamoto AY; Clé DV; Calado RT; Covas DT; Alcantara LCJ; Kashima S Infect Genet Evol; 2021 Sep; 93():104976. PubMed ID: 34174479 [TBL] [Abstract][Full Text] [Related]
28. Space-time analysis of the first year of COVID-19 pandemic in the city of Rio de Janeiro, Brazil. Santos CVBD; Cavalcante JR; Pungartnik PC; Guimarães RM Rev Bras Epidemiol; 2021; 24():e210046. PubMed ID: 34730708 [TBL] [Abstract][Full Text] [Related]
29. Genomic monitoring of the SARS-CoV-2 B1.1.7 (WHO VOC Alpha) in the Sao Paulo state, Brazil. Slavov SN; Bezerra RDS; Rodrigues ES; Santos EV; Borges JS; de la Roque DGL; Patané JSL; Lima ARJ; Ribeiro G; Viala VL; de Lima LPO; Martins AJ; Dos Santos Barros CR; Marqueze EC; Bernardino JST; Moretti DB; Brassaloti RA; Cassano RLRC; Mariani PDSC; Kitajima JP; Santos B; Assato PA; da Silva da Costa FA; Poleti MD; Lesbon JCC; Mattos EC; Banho CA; Sacchetto L; Moraes MM; Grotto RMT; Souza-Neto JA; Giovanetti M; de Alcantara LCJ; Nogueira ML; Fukumasu H; Coutinho LL; Calado RT; Neto RM; Covas DT; Coccuzzo Sampaio S; Elias MC; Kashima S Virus Res; 2022 Jan; 308():198643. PubMed ID: 34848213 [TBL] [Abstract][Full Text] [Related]
30. Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil. Resende PC; Delatorre E; Gräf T; Mir D; Motta FC; Appolinario LR; da Paixão ACD; Mendonça ACDF; Ogrzewalska M; Caetano B; Wallau GL; Docena C; Dos Santos MC; de Almeida Ferreira J; Sousa Junior EC; da Silva SP; Fernandes SB; Vianna LA; Souza LDC; Ferro JFG; Nardy VB; Santos CA; Riediger I; do Carmo Debur M; Croda J; Oliveira WK; Abreu A; Bello G; Siqueira MM Front Microbiol; 2020; 11():615280. PubMed ID: 33679622 [TBL] [Abstract][Full Text] [Related]
31. Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation. Wang H; Jean S; Eltringham R; Madison J; Snyder P; Tu H; Jones DM; Leber AL J Clin Microbiol; 2021 Jul; 59(8):e0092621. PubMed ID: 34011523 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2. Laiton-Donato K; Franco-Muñoz C; Álvarez-Díaz DA; Ruiz-Moreno HA; Usme-Ciro JA; Prada DA; Reales-González J; Corchuelo S; Herrera-Sepúlveda MT; Naizaque J; Santamaría G; Rivera J; Rojas P; Ortiz JH; Cardona A; Malo D; Prieto-Alvarado F; Gómez FR; Wiesner M; Martínez MLO; Mercado-Reyes M Infect Genet Evol; 2021 Nov; 95():105038. PubMed ID: 34403832 [TBL] [Abstract][Full Text] [Related]
33. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2. Silva MSD; Demoliner M; Hansen AW; Gularte JS; Silveira F; Heldt FH; Filippi M; Pereira VMAG; Silva FPD; Mallmann L; Fink P; Silva LLD; Weber MN; Almeida PR; Fleck JD; Spilki FR Rev Inst Med Trop Sao Paulo; 2021; 63():e58. PubMed ID: 34231823 [TBL] [Abstract][Full Text] [Related]
34. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge. Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692 [TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community. Hirotsu Y; Omata M Infect Genet Evol; 2021 Nov; 95():105088. PubMed ID: 34560289 [TBL] [Abstract][Full Text] [Related]
36. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus. Kim YJ; Jang US; Soh SM; Lee JY; Lee HR Viruses; 2021 Apr; 13(4):. PubMed ID: 33917138 [TBL] [Abstract][Full Text] [Related]
37. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338 [TBL] [Abstract][Full Text] [Related]
39. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7. Peters MH; Bastidas O; Kokron DS; Henze CE Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753 [TBL] [Abstract][Full Text] [Related]
40. Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State. Perchetti GA; Zhu H; Mills MG; Shrestha L; Wagner C; Bakhash SM; Lin MJ; Xie H; Huang ML; Mathias P; Bedford T; Jerome KR; Greninger AL; Roychoudhury P J Med Virol; 2021 Oct; 93(10):5931-5941. PubMed ID: 34170525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]